01/23/23 9:00 AMNasdaq : TNDM acquisitionTandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF MedicalTandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, today announced the completion of its previously announced acquisition of AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump. “AMF Medical's compelling technology aligns well with our strategic vision to include a patch pump in Tandem’ s portfolio of...RHEA-AIneutral
01/19/23 4:05 PMNasdaq : TNDM earningsTandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2022 results after the financial markets close on Wednesday, February 22, 2023. About Tandem Diabetes Care, Inc.. Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego,...RHEA-AIneutral
01/10/23 4:05 PMNasdaq : TNDM Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 OutlookTandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, today reported its preliminary, unaudited sales for the fourth quarter and year ended December 31, 2022 and worldwide sales outlook for the year ending December 31, 2023. GAAP sales increased to approximately $221 million from $210 million Non-GAAP sales increased to...RHEA-AIneutral
01/03/23 4:05 PMNasdaq : TNDM conferencesTandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare ConferenceTandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the 41 st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 8:15pm Eastern Time. Tandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and/or other countries and t:...RHEA-AIneutral
12/13/22 6:30 AMNasdaq : TNDM acquisitionTandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF MedicalTandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, today announced that it has entered into a definitive agreement to acquire AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump. The Sigi Patch Pump is under development and not commercially available. “This acquisition supports our commitment to drive...RHEA-AIpositive
11/16/22 4:05 PMNasdaq : TNDM Tandem Diabetes Care Earns Great Place to Work Certification™Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, is proud to announce its Great Place to Work Certification™, a prestigious award based entirely on results from in-depth employee surveys around their experience working at the company. Earning this designation means that Tandem Diabetes Care is one of the best companies...RHEA-AIvery positive
11/10/22 5:22 PMNasdaq : TNDM Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ TechnologyTandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced results from a prospective, multicenter, single-arm study of adults living with type 2 diabetes who achieved improvement in all clinical endpoints with the use of the t: slim X2 insulin pump with Control-IQ technology. 1. “The results presented today are...RHEA-AIvery positive
11/08/22 4:05 PMNasdaq : TNDM conferencesTandem Diabetes Care Announces Upcoming Conference PresentationTandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the Piper Sandler 34 th Annual Healthcare Conference on Wednesday, November 30, 2022 at 9:00am Eastern Time. Tandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and/or other countries...RHEA-AIneutral
11/02/22 4:05 PMNasdaq : TNDM earningsTandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial GuidanceTandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2022 and updated its financial guidance for the year ending December 31, 2022. Worldwide installed base increased 35 percent to more than 400,000 customers. Worldwide sales increased 14 percent to...RHEA-AIneutral
10/27/22 4:05 PMNasdaq : TNDM conferencesTandem Diabetes Care Announces Upcoming Conference PresentationsTandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:. Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with...RHEA-AIneutral